Sort   by:  
 Page size 
UnknownSubsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease.
Not available
S-EPMC8350095 | biostudies-literature
UnknownThe Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events.
Not available
S-EPMC8498597 | biostudies-literature
UnknownPlacebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Not available
S-EPMC7547938 | biostudies-literature
UnknownDifferent AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid.
Not available
S-EPMC9379489 | biostudies-literature
UnknownHigher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
Not available
S-EPMC10400628 | biostudies-literature
UnknownPolygenic effects on the risk of Alzheimer's disease in the Japanese population.
Not available
S-EPMC10898021 | biostudies-literature
Sort   by:  
 Page size